Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease

Genetics in Medicine

Volumn 14, Issue 8, 2012, Pages 742-748

  Roberts, J Scott ^a   Chen, Clara A ^b   Uhlmann, Wendy R ^c   Green, Robert C ^d  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Alzheimer disease; APOE; genetic counseling; health education; risk communication

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ATTITUDE TO ILLNESS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC COUNSELING; GENETIC HETEROGENEITY; GENETIC RISK; GENOTYPE; HUMAN; INFORMATION DISSEMINATION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; OUTCOME ASSESSMENT; PATIENT EDUCATION; RANDOMIZED CONTROLLED TRIAL; RECALL; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; DISCLOSURE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MENTAL RECALL; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; RISK;

EID: 84864659386     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2012.37     Document Type: Article

References (30)

1. American Board of Genetic Counselors website. www.abgc.net/ABGC/ AmericanBoardofGeneticCounselors.asp. Accessed 23 March 2012.
2. Guttmacher AE, Jenkins J, Uhlmann WR. Genomic medicine: who will practice it? A call to open arms. Am J Med Genet 2001;106:216-222.
3. Guttmacher AE. Human genetics on the web. Annu Rev Genomics Hum Genet 2001;2:213-233.
4. Cupples LA, Farrer LA, Sadovnick AD, Relkin N, Whitehouse P, Green RC. Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study. Genet Med 2004;6:192-196.
5. Roberts JS, Barber M, Brown TM, et al. Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial. Genet Med 2004;6:197-203.
6. LaRusse S, Roberts JS, Marteau TM, et al. Genetic susceptibility testing versus family history-based risk assessment: Impact on perceived risk of Alzheimer disease. Genet Med 2005;7:48-53.
7. Eckert SL, Katzen H, Roberts JS, et al. Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL Study. Genet Med 2006;8:746-751.
8. Christensen KD, Roberts JS, Royal CD, et al. Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience. Genet Med 2008;10:207-214.
9. Chao S, Roberts JS, Marteau TM, Silliman R, Cupples LA, Green RC. Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study. Alzheimer Dis Assoc Disord 2008;22:94-97.
10. Lipkus IM, Samsa G, Rimer BK. General performance on a numeracy scale among highly educated samples. Med Decis Making 2001;21:37-44.
11. Moscarillo TJ, Holt H, Perman M, et al. Knowledge of and attitudes about Alzheimer disease genetics: report of a pilot survey and two focus groups. Community Genet 2007;10:97-102.
12. Cull A, Miller H, Porterfield T, et al. The use of videotaped information in cancer genetic counselling: a randomized evaluation study. Br J Cancer 1998;77:830-837.
13. Evans DG, Blair V, Greenhalgh R, Hopwood P, Howell A. The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer 1994;70:934-938.
14. Lerman C, Lustbader E, Rimer B, et al. Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst 1995;87:286-292.
15. Smerecnik CM, Mesters I, Verweij E, de Vries NK, de Vries H. A systematic review of the impact of genetic counseling on risk perception accuracy. J Genet Couns 2009;18:217-228.
16. Meiser B, Halliday JL. What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Soc Sci Med 2002;54:1463-1470.
17. Julian-Reynier C, Welkenhuysen M, Hagoel L, Decruyenaere M, Hopwood P; CRISCOM Working Group. Risk communication strategies: state of the art and effectiveness in the context of cancer genetic services. Eur J Hum Genet 2003;11:725-736.
18. Green MJ, Biesecker BB, McInerney AM, Mauger D, Fost N. An interactive computer program can effectively educate patients about genetic testing for breast cancer susceptibility. Am J Med Genet 2001;103:16-23.
19. Green MJ, Peterson SK, Baker MW, et al. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial. JAMA 2004;292:442-452.
20. Wang C, Gonzalez R, Milliron KJ, Strecher VJ, Merajver SD. Genetic counseling for BRCA1/2: a randomized controlled trial of two strategies to facilitate the education and counseling process. Am J Med Genet A 2005;134A:66-73.
21. Graves KD, Wenzel L, Schwartz MD, et al. Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2010;19:648-654.
22. Peshkin BN, Demarco TA, Graves KD, et al. Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial. Genet Test 2008;12:37-52.
23. Jenkins J, Calzone KA, Dimond E, et al. Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling. Genet Med 2007;9:487-495.
24. Hunter DJ, Khoury MJ, Drazen JM. Letting the genome out of the bottle-will we get our wish? N Engl J Med 2008;358:105-107.
25. Wolfberg AJ. Genes on the Web-direct-to-consumer marketing of genetic testing. N Engl J Med 2006;355:543-545.
26. Offit K. Genomic profiles for disease risk: predictive or premature? JAMA 2008;299:1353-1355.
27. Sheridan SL, Halpern DJ, Viera AJ, Berkman ND, Donahue KE, Crotty K. Interventions for individuals with low health literacy: a systematic review. J Health Commun 2011;16(suppl 3):30-54.
28. Stacey D, Bennett CL, Barry MJ, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2011;CD001431.
29. Food and Drug Administration. Communicating Risks and Benefits: An Evidence-Based User's Guide. US Department of Health and Human Services: Silver Springs, MD, 2011.
30. McBride CM, Alford SH, Reid RJ, Larson EB, Baxevanis AD, Brody LC. Putting science over supposition in the arena of personalized genomics. Nat Genet 2008;40:939-942.